RxDoctor Payments Data

Steven Willi

Pediatric Endocrinology · Philadelphia, PANPI 1972511392

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Boehringer Ingelheim International GmbH accounts for 69.0% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $8,231 and has fallen 94.8% since, to $428 in 2025. Among pediatric endocrinology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$34,221in general payments, 2019–2025

Across 42 payments — averaging $814.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim International GmbH$24K
  • Medtronic$8K
  • Merck$2K
  • Sanofi-aventis U.S. LLC$508
  • Novo Nordisk$124
$1,342,182in research payments, 2019–2025

Across 251 payments — averaging $5347.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$404K
  • Sanofi US Services Inc.$255K
  • Mannkind Corporation$186K
  • Boehringer Ingelheim$149K
  • Merck$88K
  • Janssen Research & Development, LLC$84K
  • plus $176K from 7 others

What the payments were for

  • Consulting fees$18,76055%
  • Speaking & faculty fees$13,57340%
  • Travel & lodging$1,1963%
  • Food & beverage$6922%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boehringer Ingelheim International GmbH22$23,623
Medtronic(2 entities)6$8,460
Merck9$1,506
Sanofi-aventis U.S. LLC4$508
Novo Nordisk1$124

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,221 in reported general payments places this provider in the 90th percentile of 80 pediatric endocrinology providers in Pennsylvania.

See all pediatric endocrinology providers in Pennsylvania →

Other pediatric endocrinology in Philadelphia

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →